Indeed, increasing evidences in patients with MS and EAE models have suggested that both the NLRP3 inflammasome activation and pyroptosis in microglia account for the robust inflammation and the deterioration in the progress of this disease [21]. This evidence concerns the gene NLRP3 and myeloid sarcoma.